Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: overview and pharmacology.
D000547:Amantadine / Q000378:metabolism / Q000627:therapeutic use*; D000818:Animals; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001058:Apomorphine / Q000494:pharmacology; D001480:Basal Ganglia Diseases / Q000139:chemically induced / Q000188:drug therapy*; D001667:Binding, Competitive; D002069:Butaclamol / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D013134:Spiperone / Q000378:metabolism
D014150:Antipsychotic Agents; D013134:Spiperone; D002069:Butaclamol; D000547:Amantadine; D001058:Apomorphine